Products

What will AGI do for Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine?

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The World Health Organization schedules caffeine in its Anatomical Therapeutic Chemical (ATC) Classification. The third component of this combination drug is a histamine-1 receptor antagonist, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3U6IO1965U. The European Medicines Agency schedules Chlorphenamine (under maleate form) in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01243MIG. Chlorpheniramine generally arises in the molecular formula C16H19ClN2. The term 'chlorpheniramine maleate' is a European Pharmacopoeia designation. The fourth component of this combination drug is an opioid receptor agonist and opioid and antitussive agent with the molecular formula C18H21NO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 6YKS4Y3WQ7, chemically known as 4,5-epoxy-3-methoxy-17-methylmorphinan-6-one but more generally known as hydrocodone, which bears U.S. National Institutes of Health Compound Identifier 5284569. The European Medicines Agency schedules Hydrocodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08063MIG. The term HYDROCODONE is an International Non-Proprietary Name. The World Health Organization schedules hydrocodone in its Anatomical Therapeutic Chemical (ATC) Classification. The fifth component of this combination drug is an alpha-adrenergic agonist with the molecular formula C9H13NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1WS297W6MV, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears U.S. National Institutes of Health Compound Identifier 6041. TRUNCATED